Sometimes literary gimmicks backfire. In May 2015, we premiered “Cisco, Chang & Charlie” (sans Oxford comma) as a James Joycean brooding on the letter C, third letter of the alphabet, in three iterations. At the time, three stocks whose names begin with C were vying for attention and prompting questions from readers. The original plan […]
Articles
[Ed. Note: Dr. KSS writes for the Irregulars about medicine and biotech stocks. He chooses his own topics, and his words and opinions are his own.] Careful analysis of Ebola sequences in infected Africans confirms this: the entire present Ebola outbreak emerged as a consequence of one boy in Meliandoua, in eastern Guinea, eating a […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. His words and opinions are his own.] In A History of New York, Washington Irving opens chapter VIII thus: ”In which the author and reader…fall into a very grave and instructive discourse.” This may prove to be a more unleavened column than […]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
Calc Risk - Thanks for the additional input. I think you are our new Devil Dog. ... Speaking of which does anyone have...
Paul's TM, Sell: SRPT Paul's Secret Portfolio, Buy: EXPC...
Can you please share the entry point on SRPT, thank you in advance.....
Hey! Thanks for the New Era Fortunes tip, really appreciate it and will look into BLFS. He still has SRPT, I'll let you ...
Any Idea on SRPT if still on hold or sell, went down big time today, would appreciate the info. Also did subscribe the N...
$SRPT #DMD #Exondyl51: FDA can approve, but payers refuse to cover *Analysts track a payer revolt against Sarepta’s...
I am talking to day about Sarepta . I am long srpt and I am only a small time trader. About $1000 in Serendipity w...
$TRIL - I'm not so sure that is necessarily a vote of confidence that should make us feel good about TRIL. In that arti...
Summit is a small UK firm planning to IPO in the US. I was pleasantly surprised by what I found researching this one, th...
But there is some bad news for Sarepta (SRPT). Down ~40% in pre-market as FDA is once again requiring additional data o...
Hey Anshuman,hope you are doing well. Oncogenix,Prosensa and Sarepta trade on the Nasdaq market.Stock symbols are Oncoge...
Sarepta (SRPT) has come up for discussion. This is a gnarly company in gnarly situation going after a gnarly disease (D...